Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-01 MacBeath Gavin Chief Executive Officer Grant or award +1,000,000 1,049,767
2026-01-20 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,165,000 1,165,000
2025-01-03 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +800,000 800,000
2024-01-12 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +160,000 160,000
2023-06-13 MacBeath Gavin Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,121,300 1,121,300
2023-02-02 MacBeath Gavin See Remarks Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-07-25 MacBeath Gavin See Remarks Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-01-18 MacBeath Gavin Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2021-09-21 MacBeath Gavin Chief Scientific Officer Purchase +57 $6.19 $353 49,767
2021-09-20 MacBeath Gavin Chief Scientific Officer Purchase +4,943 $6.22 $31K 49,710

Page 1 of 1 · 10 trades